These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3946110

  • 1. Lisuride in the treatment of myoclonus.
    Obeso JA, Rothwell JC, Quinn NP, Lang AE, Artieda J, Marsden CD.
    Adv Neurol; 1986; 43():191-6. PubMed ID: 3946110
    [No Abstract] [Full Text] [Related]

  • 2. Dopamine agonists suppress visual-cortical reflex myoclonus.
    Obeso JA, Artieda J, Tuñón T, Luquin MR, Martínez Lage JM.
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1277-83. PubMed ID: 3936901
    [Abstract] [Full Text] [Related]

  • 3. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist.
    Lieberman AN, Goldstein M, Neophytides A, Leibowitz M, Gopinathan G, Goodgold A, Pact V, Walker R.
    N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052
    [No Abstract] [Full Text] [Related]

  • 4. Cortical reflex myoclonus responds to intravenous lisuride.
    Obeso JA, Rothwell JC, Quinn NP, Lang AE, Thompson C, Marsaden CD.
    Clin Neuropharmacol; 1983 Nov; 6(3):231-40. PubMed ID: 6414686
    [Abstract] [Full Text] [Related]

  • 5. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients.
    Rabey JM, Treves T, Streifler M, Korczyn AD.
    Adv Neurol; 1987 Nov; 45():569-72. PubMed ID: 3825734
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Oral lisuride in Parkinson's disease].
    Obeso JA, Luquin MR, Martínez Lage JM.
    Med Clin (Barc); 1985 Sep 21; 85(8):307-12. PubMed ID: 4068822
    [No Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion.
    Rodriguez ME, Luquin MR, Lera G, Delgado G, Salazar JM, Obeso JA.
    Mov Disord; 1990 Sep 21; 5(2):170-2. PubMed ID: 2325680
    [Abstract] [Full Text] [Related]

  • 9. Lisuride in the treatment of Parkinsonism.
    Schachter M, Sheehy MP, Parkes JD, Marsden CD.
    Acta Neurol Scand; 1980 Dec 21; 62(6):382-5. PubMed ID: 7468157
    [Abstract] [Full Text] [Related]

  • 10. Carbidopa/levodopa-responsive myoclonus.
    Fitzgerald DB, Drago V, Sutherland D, Heilman KM.
    Mov Disord; 2007 Feb 15; 22(3):392-5. PubMed ID: 17216651
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
    Lieberman A, Goldstein M, Neophytides A, Kupersmith M, Leibowitz M, Zasorin N, Walker R, Kleinberg D.
    Neurology; 1981 Aug 15; 31(8):961-5. PubMed ID: 7022259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Walker R, Hiesiger E.
    Ann Neurol; 1983 Jan 15; 13(1):44-7. PubMed ID: 6830164
    [Abstract] [Full Text] [Related]

  • 15. The use of lisuride in severe Parkinson's disease.
    Chin D, Yu YL, Huang CY.
    Clin Exp Neurol; 1986 Jan 15; 22():63-9. PubMed ID: 3581512
    [Abstract] [Full Text] [Related]

  • 16. [Contribution to the treatment of headache with lisuride].
    Lazzaroni A, Savonelli C, Bianchi MG, Mallucci C, Maggi GC.
    Clin Ter; 1984 Jun 15; 109(5):433-9. PubMed ID: 6236934
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Terguride in the treatment of hyperprolactinemia and acromegaly].
    Marek J, Bauer J, Srámková J, Hána V.
    Cas Lek Cesk; 1986 Jan 24; 125(4):100-5. PubMed ID: 3948223
    [No Abstract] [Full Text] [Related]

  • 19. Lisuride as a migraine prophylactic in children: an open clinical trial.
    Del Bene E, Poggioni M, Michelacci S.
    Int J Clin Pharmacol Res; 1983 Jan 24; 3(2):137-41. PubMed ID: 6679514
    [Abstract] [Full Text] [Related]

  • 20. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ, Sharpless NS, Wolfson L, Katzman R.
    Ann Neurol; 1980 Jun 24; 7(6):570-6. PubMed ID: 6969054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.